Market Research Logo

Europe Melanoma Market and Competitive Landscape – 2017

Europe Melanoma Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Europe Melanoma Market and Competitive Landscape – 2017, provides comprehensive insights into Melanoma pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Melanoma market size and drug sales. This research also provides insights into Melanoma epidemiology and late stage pipeline.
The report is classified into nine sections – Melanoma overview with definitions, symptoms, etiology, diagnosis, treatment options; Melanoma pipeline insights covering late stage clinical trials pipeline; Melanoma prevalence trends by countries; Melanoma market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries – Germany, France, Italy, Spain, UK, Europe.

Research Scope:

  • Melanoma pipeline: Find out the drugs in clinical trials for Melanoma by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Melanoma epidemiology: Find out the prevalence of Melanoma by countries – Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Melanoma products: Identify key products marketed and prescribed for Melanoma by brand name, by molecule, by company, by branded / generic, by countries – Europe, Germany, France, Italy, Spain, UK, Japan
  • Melanoma market size: Find out the market size for Melanoma drugs by countries – Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Melanoma drug sales: Find out the sales of Melanoma drugs by countries – Europe, Germany, France, Italy, Spain, UK
  • Melanoma drugs sales forecast: Sales forecast for Melanoma drugs to 2021 by countries – Europe, Germany, France, Italy, Spain, UK, Japan
  • Melanoma market share analysis: Find out the market shares of Melanoma drugs and outlook by countries – Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Melanoma drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Melanoma market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Melanoma market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


1. Melanoma: Disease Overview
1.1. Melanoma Symptoms
1.2. Melanoma Etiology
1.3. Melanoma Diagnosis
1.4. Melanoma Treatment Options
2. Melanoma Pipeline Insights
2.1. Melanoma Phase 3 Clinical Trials
2.2. Melanoma Phase 2 Clinical Trials
2.3. Melanoma Phase 1 Clinical Trials
3. Melanoma Epidemiology Analysis
4. Germany Melanoma Market Insights
4.1. Marketed Products for Melanoma in Germany
4.2. Germany Melanoma Market Size & Forecast
4.3. Germany Melanoma Product Sales Forecast
4.4. Germany Melanoma Market Share Analysis
5. France Melanoma Market Insights
5.1. Marketed Products for Melanoma in France
5.2. France Melanoma Market Size & Forecast
5.3. France Melanoma Product Sales Forecast
5.4. France Melanoma Market Share Analysis
6. Italy Melanoma Market Insights
6.1. Marketed Products for Melanoma in Italy
6.2. Italy Melanoma Market Size & Forecast
6.3. Italy Melanoma Product Sales Forecast
6.4. Italy Melanoma Market Share Analysis
7. Spain Melanoma Market Insights
7.1. Marketed Products for Melanoma in Spain
7.2. Spain Melanoma Market Size & Forecast
7.3. Spain Melanoma Product Sales Forecast
7.4. Spain Melanoma Market Share Analysis
8. UK Melanoma Market Insights
8.1. Marketed Products for Melanoma in UK
8.2. UK Melanoma Market Size & Forecast
8.3. UK Melanoma Product Sales Forecast
8.4. UK Melanoma Market Share Analysis
9. Europe Melanoma Market Insights
9.1. Europe Melanoma Market Size & Forecast
9.2. Europe Melanoma Product Sales Forecast
9.3. Europe Melanoma Market Share Analysis
10. Research Methodology
LIST OF TABLES
Table 1: Melanoma Phase 3 Clinical Trials, Global, 2017
Table 2: Melanoma Phase 2 Clinical Trials, Global, 2017
Table 3: Melanoma Phase 1 Clinical Trials, Global, 2017
Table 4: Melanoma Prevalence by EU5 Countries, 2012 - 2021
Table 5: Marketed Products for Melanoma in Germany, 2017
Table 6: Germany Melanoma Market Size & Forecast ($mn), 2012 - 2021
Table 7: Germany Melanoma Product Sales ($mn), 2012 - 2021
Table 8: Germany Melanoma Market Trends, 2012 - 2021
Table 9: Marketed Products for Melanoma in France, 2017
Table 10: France Melanoma Market Size & Forecast ($mn), 2012 - 2021
Table 11: France Melanoma Product Sales ($mn), 2012 - 2021
Table 12: France Melanoma Market Trends, 2012 - 2021
Table 13: Marketed Products for Melanoma in Italy, 2017
Table 14: Italy Melanoma Market Size & Forecast ($mn), 2012 - 2021
Table 15: Italy Melanoma Product Sales ($mn), 2012 - 2021
Table 16: Italy Melanoma Market Trends, 2012 - 2021
Table 17: Marketed Products for Melanoma in Spain, 2017
Table 18: Spain Melanoma Market Size & Forecast ($mn), 2012 - 2021
Table 19: Spain Melanoma Product Sales ($mn), 2012 - 2021
Table 20: Spain Melanoma Market Trends, 2012 - 2021
Table 21: Marketed Products for Melanoma in UK, 2017
Table 22: UK Melanoma Market Size & Forecast ($mn), 2012 - 2021
Table 23: UK Melanoma Product Sales ($mn), 2012 - 2021
Table 24: UK Melanoma Market Trends, 2012 - 2021
Table 25: Europe Melanoma Market Size & Forecast ($mn), 2012 - 2021
Table 26: Europe Melanoma Product Sales ($mn), 2012 - 2021
LIST OF FIGURES
Figure 1: Melanoma Pipeline by Phase (%), Global, 2017
Figure 2: Melanoma Prevalence by EU5 Countries, 2012 - 2021
Figure 3: Germany Melanoma Market Size ($mn), 2012 - 2021
Figure 4: Germany Melanoma Product Sales ($mn), 2012 - 2021
Figure 5: Germany Melanoma Market Share by Products (%), 2016
Figure 6: Germany Melanoma Market - Future Market Share (%), 2021
Figure 7: France Melanoma Market Size ($mn), 2012 - 2021
Figure 8: France Melanoma Product Sales ($mn), 2012 - 2021
Figure 9: France Melanoma Market Share by Products (%), 2016
Figure 10: France Melanoma Market - Future Market Share (%), 2021
Figure 11: Italy Melanoma Market Size ($mn), 2012 - 2021
Figure 12: Italy Melanoma Product Sales ($mn), 2012 - 2021
Figure 13: Italy Melanoma Market Share by Products (%), 2016
Figure 14: Italy Melanoma Market - Future Market Share (%), 2021
Figure 15: Spain Melanoma Market Size ($mn), 2012 - 2021
Figure 16: Spain Melanoma Product Sales ($mn), 2012 - 2021
Figure 17: Spain Melanoma Market Share by Products (%), 2016
Figure 18: Spain Melanoma Market - Future Market Share (%), 2021
Figure 19: UK Melanoma Market Size ($mn), 2012 - 2021
Figure 20: UK Melanoma Product Sales ($mn), 2012 - 2021
Figure 21: UK Melanoma Market Share by Products (%), 2016
Figure 22: UK Melanoma Market - Future Market Share (%), 2021
Figure 23: Europe Melanoma Market Size ($mn), 2012 - 2021
Figure 24: Europe Melanoma Product Sales ($mn), 2012 - 2021
Figure 25: Europe Melanoma Market Share by Products (%), 2016
Figure 26: Europe Melanoma Market - Future Market Share (%), 2021

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report